Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Deseret News Utah Index
Deseret News Composite
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longeveron Inc
(NQ:
LGVN
)
2.350
-0.110 (-4.47%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Longeveron Inc
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
April 08, 2022
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now.
Via
InvestorPlace
A Peek Into The Markets: US Stock Futures Down Ahead Of Fed Minutes
April 06, 2022
Pre-open movers
Via
Benzinga
5 Stocks To Watch For April 6, 2022
April 06, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.30 per share on revenue of $1.41 million before the...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
April 05, 2022
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
April 05, 2022
Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday!
Via
InvestorPlace
68 Biggest Movers From Yesterday
April 05, 2022
Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
April 04, 2022
Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. Trading volume for Cognition Therapeutics's stock...
Via
Benzinga
35 Stocks Moving In Monday's Mid-Day Session
April 04, 2022
Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors. Jumia Technologies AG (...
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 04, 2022
Via
Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 01, 2022
Gainers Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4...
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
April 01, 2022
Good morning, investor! It's the last trading day of the week and that means it's time to get into the pre-market stock movers for Friday!
Via
InvestorPlace
21 Stocks Moving in Friday's Pre-Market Session
April 01, 2022
Gainers Blackboxstocks Inc. (NASDAQ: BLBX) rose 37.6% to $3.69 in pre-market trading after the company reported better-than-expected Q4 sales results. Chicken Soup for the Soul...
Via
Benzinga
53 Biggest Movers From Yesterday
April 01, 2022
Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing...
Via
Benzinga
Mid-Afternoon Market Update: Dow Falls 180 Points; Creative Medical Technology Shares Spike Higher
March 31, 2022
U.S. stocks traded lower toward the end of trading following the release of weekly jobless claims data. The Dow traded down 0.52% to 35,043.99 while the NASDAQ fell 0.22% to 14,...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 31, 2022
Gainers Longeveron (NASDAQ:LGVN) stock rose 60.6% to $10.79 during Thursday's regular session. As of 13:31 EST, this security is trading at a volume of 84.1 million...
Via
Benzinga
36 Stocks Moving In Thursday's Mid-Day Session
March 31, 2022
Gainers Longeveron Inc. (NASDAQ: LGVN) shares climbed 71% to $11.57 after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients with...
Via
Benzinga
Is NIO Stock a Buy? What the Bulls and Bears Are Saying.
March 31, 2022
Nio (NIO) stock is sliding lower on Thursday after rallying earlier this week and that has some investors wondering if the stock is a buy.
Via
InvestorPlace
Alzheimer’s News: Why Is Drugmaker Longeveron (LGVN) Soaring Today?
March 31, 2022
Longeveron (LGVN) stock is taking off on Thursday after the drugmaker published news related to an Alzheimer's treatment.
Via
InvestorPlace
Mid-Day Market Update: Crude Oil Down Over 3%; RCM Technologies Shares Jump
March 31, 2022
U.S. stocks traded lower midway through trading following the release of weekly jobless claims data.
Via
Benzinga
Analyzing Longeveron Inc. - common stock's Short Interest
March 31, 2022
Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has fallen 10.14% since its last report. The company recently reported that it has 412.90 thousand shares...
Via
Benzinga
Mid-Morning Market Update: US Markets Open Lower As Initial Jobless Claims Rise
March 31, 2022
U.S. stocks opened on a weak note this morning following the release of weekly jobless claims data.
Via
Benzinga
Why Longeveron Shares Are Surging Today
March 31, 2022
Longeveron Inc (NASDAQ: LGVN) shares are trading higher Thursday after the company announced the publication of results from a Phase 1 trial testing Lomecel-B on patients...
Via
Benzinga
R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development
March 31, 2022
Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia...
Via
FinancialNewsMedia
EXCLUSIVE: Longeveron's Lomecel-B Data In Alzheimer's Disease Published In Medical Journal
March 31, 2022
Longeveron Inc (NASDAQ: LGVN) announced the publication of Phase 1 trial results of Lomecel-B on patients with mild Alzheimer's disease (AD) in the Alzheimer's & Dementia journal.
Via
Benzinga
Healthspan, Not Lifespan Should Be the Focus of Anti-Aging Research, Says Longeveron
March 30, 2022
This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 24, 2022
March 24, 2022
Upgrades For iRobot Corp (NASDAQ:IRBT), Northland Capital Markets upgraded the previous rating of Market Perform to Outperform. In the fourth quarter, iRobot showed an EPS of $1....
Via
Benzinga
5 Cheap Energy Stocks Riding Oil Higher
March 23, 2022
Energy is understandably at the top of every investor's mind right now, but finding the best energy stocks requires careful consideration.
Via
InvestorPlace
My No. 2 Stock Pick For 2022 Rises 100%…
March 15, 2022
There isn't just one kind of good stock, and there isn't just one good strategy for when to sell. You need a variety of approaches.
Via
InvestorPlace
Longeveron Announces Fourth Quarter And Full Year 2021 Financial Results And Operational Progress
March 14, 2022
Currently Enrolling Clinical Trials with Lomecel-B in Three Disease Indications: Hypoplastic Left Heart Syndrome (Phase 2a), Alzheimer’s Disease (Phase 2a), and Covid-...
Via
Benzinga
< Previous
1
2
...
9
10
11
12
13
14
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.